A61K 2039/552
Veterinary vaccine
Official title: {Veterinary vaccine}
A61K2039/552 (Veterinary vaccine) appears on 1,980 US grants and 2,546 published applications in this corpus.
Search patents in A61K- Granted patents
- 1,980
- Published applications
- 2,546
- Assignees
- 983
- Inventors
- 4,164
- Latest grant
- 8 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 7 | 0 |
| 1977 | 11 | 0 |
| 1978 | 5 | 0 |
| 1979 | 3 | 0 |
| 1980 | 10 | 0 |
| 1981 | 7 | 0 |
| 1982 | 10 | 0 |
| 1983 | 3 | 0 |
| 1984 | 8 | 0 |
| 1985 | 10 | 0 |
| 1986 | 7 | 0 |
| 1987 | 13 | 0 |
| 1988 | 11 | 0 |
| 1989 | 9 | 0 |
| 1990 | 6 | 0 |
| 1991 | 18 | 0 |
| 1992 | 7 | 0 |
| 1993 | 11 | 0 |
| 1994 | 5 | 0 |
| 1995 | 12 | 0 |
| 1996 | 12 | 0 |
| 1997 | 22 | 0 |
| 1998 | 20 | 0 |
| 1999 | 28 | 0 |
| 2000 | 31 | 0 |
| 2001 | 22 | 8 |
| 2002 | 27 | 35 |
| 2003 | 31 | 56 |
| 2004 | 21 | 66 |
| 2005 | 28 | 51 |
| 2006 | 35 | 46 |
| 2007 | 40 | 76 |
| 2008 | 47 | 85 |
| 2009 | 34 | 97 |
| 2010 | 56 | 102 |
| 2011 | 49 | 108 |
| 2012 | 45 | 86 |
| 2013 | 57 | 115 |
| 2014 | 78 | 116 |
| 2015 | 82 | 117 |
| 2016 | 98 | 151 |
| 2017 | 122 | 163 |
| 2018 | 144 | 134 |
| 2019 | 118 | 138 |
| 2020 | 108 | 136 |
| 2021 | 111 | 115 |
| 2022 | 80 | 134 |
| 2023 | 74 | 112 |
| 2024 | 65 | 101 |
| 2025 | 76 | 115 |
| 2026 | 46 | 83 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Coronavirus vaccines compositions and method of using same8 Sep 2026US 12,728,159 B2Loyola University of Chicago
- Immune priming to accelerate/enhance immune response through administration of natural immune modulator1 Sep 2026US 12,721,889 B2ZIVO Bioscience, Inc.
- Proteins and immunizing compositions containing Klebsiella proteins and methods of use28 Jul 2026US 12,691,167 B2Vaxxinova US, Inc.
- Modified gene vaccines against avian coronaviruses and methods of using the same21 Jul 2026US 12,685,766 B2Wisconsin Alumni Research Foundation
- Polynucleotides encoding SARS-COV-2 antigens and use thereof in the medical field as vaccines7 Jul 2026US 12,673,095 B2Takis S.R.L.
- Method for inducing an immune response8 Oct 2026US 2026/0306617 A1Acclarent, Inc.
- A vaccine against erysipelothrix rhusiopathiae and porcine parvo virus8 Oct 2026US 2026/0306618 A1Intervet Inc.
- Orally-delivered vaccines for domesticated and wild animals to prevent pathogen spread using recombinant probiotic bacteria1 Oct 2026US 2026/0295027 A1
- Horn fly vaccine compositions and methods of making same24 Sep 2026US 2026/0285920 A1TNG Pharmaceuticals, Inc.
- Non-coding rna peptide antigens for cancer vaccines, therapeutics, and diagnostics17 Sep 2026US 2026/0273034 A1Calviri, Inc.
Most cited
By later US patents
- Antigenically active amino acid sequences190US 4,708,871 ACommonwealth Serum Laboratories Commission · 1987
- System and method for measuring animals128US 8,036,429 B22011
- European vaccine strains of the porcine reproductive and respiratory syndrome virus110US 5,925,359 AAkzo Nobel N. V. · 1999
- Avirulent microbes and uses therefor: Salmonella typhi109US 5,387,744 AWashington University · 1995
- Interleukin-31 monoclonal antibody106US 10,421,807 B2Zoetis Services LLC · 2019